Jove
Visualize
Contact Us

Related Experiment Videos

Antibody production: polyclonal-derived biotherapeutics.

Claire Newcombe1, Anthony R Newcombe

  • 1Process Development Group, Protherics UK Ltd, Blaenwaun, Ffostrasol, Llandysul, Wales SA44 5JT, UK.

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|August 9, 2006
PubMed
Summary

Polyclonal antibody therapeutics, though often overlooked, are vital for neutralizing viruses, toxins, and treating immune deficiencies. Recent advancements highlight their significant, ongoing role in modern medicine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Evolution of quality by design (QbD) for biologics.

PDA journal of pharmaceutical science and technology·2014
Same author

Biopharmaceutical production: Applications of surface plasmon resonance biosensors.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2009
Same author

Global Sensitivity Analysis for the determination of parameter importance in bio-manufacturing processes.

Biotechnology and applied biochemistry·2008
Same author

Evaluation of a novel agarose-based synthetic ligand adsorbent for the recovery of antibodies from ovine serum.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2007
Same author

A prototype software methodology for the rapid evaluation of biomanufacturing process options.

Biotechnology and applied biochemistry·2007
Same author

Purification of antibodies using the synthetic affinity ligand absorbent MAbsorbent A2P.

Nature protocols·2007
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Immunology
  • Therapeutics
  • Biotechnology

Background:

  • Monoclonal antibodies dominate therapeutic research, overshadowing polyclonal antibody treatments.
  • Polyclonal antibodies were historically significant but declined with antibiotic development.
  • Current applications include viral/toxin neutralization and immunoglobulin replacement therapy.

Purpose of the Study:

  • To review current techniques and applications of polyclonal antibody therapeutics.
  • To assess the future potential of polyclonal antibody-derived treatments.
  • To highlight the often-overlooked clinical importance of polyclonal antibodies.

Main Methods:

  • Review of contemporary techniques in polyclonal antibody production and purification.
  • Analysis of current clinical applications and case studies.

Related Experiment Videos

  • Assessment of existing literature on immunomodulatory and anti-inflammatory effects.

    • Main Results:

    • Intravenous immunoglobulins demonstrate significant immunomodulatory and anti-inflammatory effects.
    • Hyperimmune antibody preparations are effective in treating diverse conditions like digoxin toxicity, snake envenomation, and spider bites.
    • Polyclonal antibodies remain crucial for specific infections and medical emergencies.

    Conclusions:

    • Polyclonal antibody therapeutics possess significant, underappreciated therapeutic value.
    • Continued research and application of polyclonal antibodies are essential for addressing various diseases and infections.
    • Future potential lies in refining techniques and expanding applications for polyclonal antibody treatments.